Skip to content

Is Brain Insulin Resistance a Feature of the Biology of Depression in Adolescents

Major Depressive Disorder | Depression

This study will examine if brain insulin resistance is a feature of depression in humans using magnetic resonance imaging (MRI) measures sensitive to brain insulin action. This study will examine adolescents, as depression onset commonly occurs during this age, and the impacts of cumulative medication exposure and other lifestyle-related confounds are also lower in this age group, improving our ability to understand the underlying biology.

null

Conditions de participation

  • Sexe:

    ALL
  • Âges admissibles:

    14 to 18

Critères de participation

Inclusion Criteria:

* Age 14- 18
* One of the following: Diagnosis of Major Depressive Disorder (MDD) or Persistent Depressive Disorder (PDD); or score ≥22 on the Mood and Feeling Questionnaire and confirmation of depression with the Mini International Neuropsychiatric Interview Kid (MINI Kid)
* BMI between 5-95th population percentile and Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) ≤2.5 calculated using fasting blood work values (glucose and insulin)

Exclusion Criteria:

* History of primary psychotic illness
* Use of antipsychotics or mood stabilizers
* History of current substance use disorder (moderate to severe)
* Pre-diabetes or diabetes (fasting glucose ≥6.0 mmol/l or use of anti-diabetic drug)
* Evidence of impaired glucose tolerance on screening oral glucose tolerance test (OGTT)
* Use of weight, lipids, or blood pressure reducing agents
* History of liver disease or AST\>2 times upper limit of normal
* History of kidney disease
* MRI contraindications
* Positive pregnancy test
* Allergic to exogenous insulin
* Positive result on urine drug screen (participants with positive cannabis and alcohol urine drug screens may still be eligible for the study; positive drug screens for other substances will be exclusionary)

Lieu de l'étude

Centre for Addiction and Mental Health
Centre for Addiction and Mental Health
Toronto, Ontario
Canada

Contactez l'équipe d'étude

Primary Contact

Mahavir Agarwal, MD, PhD

[email protected]
4165358501
Backup Contact

Maria Papoulias

[email protected]
4165358501
Étude parrainée par
Centre for Addiction and Mental Health
Participants recherchés
Plus d'informations
ID de l'étude: NCT05571878